123 related articles for article (PubMed ID: 14766368)
21. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat.
Brzozowski T; Konturek PC; Konturek SJ; Kwiecién S; Pajdo R; Brzozowska I; Hahn EG
J Clin Gastroenterol; 1998; 27 Suppl 1():S125-37. PubMed ID: 9872509
[TBL] [Abstract][Full Text] [Related]
22. Central nervous system cholecystokinin and the control of feeding behavior in sheep.
Della-Fera MA; Baile CA
Prog Clin Biol Res; 1985; 192():115-22. PubMed ID: 3001747
[TBL] [Abstract][Full Text] [Related]
23. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
[TBL] [Abstract][Full Text] [Related]
24. Cholecystokinin and learning and memory processes.
Hadjiivanova C; Belcheva S; Belcheva I
Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153
[TBL] [Abstract][Full Text] [Related]
25. Endogenous CCK depresses contractile activity within the ascending myenteric reflex pathway of rat ileum.
Storr M; Sattler D; Hahn A; Schusdziarra V; Allescher HD
Neuropharmacology; 2003 Mar; 44(4):524-32. PubMed ID: 12646289
[TBL] [Abstract][Full Text] [Related]
26. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.
Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
Zavros Y; Shulkes A
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
[TBL] [Abstract][Full Text] [Related]
28. [Cholecystokinin receptors involved in the central and peripheral nervous control mechanisms in gastric acid secretion].
Watanabe K; Yano S; Mitani H
Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):153-62. PubMed ID: 7959408
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors.
Tirassa P; Stenfors C; Lundeberg T; Aloe L
Br J Pharmacol; 1998 Mar; 123(6):1230-6. PubMed ID: 9559909
[TBL] [Abstract][Full Text] [Related]
30. Biological actions of cholecystokinin.
Crawley JN; Corwin RL
Peptides; 1994; 15(4):731-55. PubMed ID: 7937354
[TBL] [Abstract][Full Text] [Related]
31. The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis.
Ebenezer IS
Eur J Pharmacol; 2003 Feb; 461(2-3):113-8. PubMed ID: 12586206
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats.
Reidelberger RD; Varga G; Liehr RM; Castellanos DA; Rosenquist GL; Wong HC; Walsh JH
Am J Physiol; 1994 Oct; 267(4 Pt 2):R901-8. PubMed ID: 7524371
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis of a cholecystokinin system in human and rat white adipose tissue.
Plaza A; Merino B; Sánchez-Pernaute A; Torres-García AJ; Rubio-Herrera MA; Ruiz-Gayo M
Life Sci; 2018 Aug; 206():98-105. PubMed ID: 29800537
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin in psychiatric research: a time for cautious excitement.
Abelson JL
J Psychiatr Res; 1995; 29(5):389-96. PubMed ID: 8748063
[TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin is involved in triglyceride fatty acid uptake by rat adipose tissue.
Plaza A; Merino B; Cano V; Domínguez G; Pérez-Castells J; Fernández-Alfonso MS; Sengenès C; Chowen JA; Ruiz-Gayo M
J Endocrinol; 2018 Mar; 236(3):137-150. PubMed ID: 29339381
[TBL] [Abstract][Full Text] [Related]
36. Involvement of endogenous CCK and CCK1 receptors in colonic motor function.
Varga G; Bálint A; Burghardt B; D'Amato M
Br J Pharmacol; 2004 Apr; 141(8):1275-84. PubMed ID: 15100163
[TBL] [Abstract][Full Text] [Related]
37. Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists.
Niederau C; Grendell JH
Digestion; 1999; 60 Suppl 1():69-74. PubMed ID: 10026436
[TBL] [Abstract][Full Text] [Related]
38. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
Brenner LA; Ritter RC
Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
[TBL] [Abstract][Full Text] [Related]
39. CCK antagonists and CCK-monoamine interactions in the control of satiety.
Cooper SJ; Dourish CT; Clifton PG
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):291S-295S. PubMed ID: 1728842
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin/Cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats.
Lubbers T; de Haan JJ; Luyer MD; Verbaeys I; Hadfoune M; Dejong CH; Buurman WA; Greve JW
Ann Surg; 2010 Aug; 252(2):376-82. PubMed ID: 20585240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
